What Happened
Kotak Institutional Equities has highlighted that ITC's tobacco business is currently valued at a mere 11x forward earnings, indicating a significant undervaluation by the market. This assessment challenges the prevailing market perception of the conglomerate's core business.
Why It Matters (for you)
This analysis is crucial for Indian investors as it points to a potential mispricing of a large-cap stock like ITC. If Kotak's view holds, there's considerable room for re-rating, especially given the growing contribution and stronger growth prospects of ITC's non-tobacco segments, which could lead to a demerger and unlock shareholder value.
Impact on Indian Markets
The primary beneficiary of this analysis is ITC (ITC) itself, with a positive impact expected on its stock price. A re-evaluation of its tobacco business, coupled with the growth of its FMCG and hotel segments, could attract more institutional interest and drive up its valuation. Other FMCG players might see indirect positive sentiment if the market starts to re-rate diversified conglomerates more favorably.
What Traders Should Watch Next
Traders should monitor any further reports or analyst upgrades on ITC. Key catalysts to watch include any official statements or rumors regarding a potential demerger of its businesses, which would be a major value-unlocking event. Also, keep an eye on the performance of its non-tobacco segments for continued growth momentum.
Key Evidence
- Kotak Securities estimates ITC’s tobacco business is valued at just 11X forward earnings.
- Kotak believes this valuation suggests potential undervaluation.
- The brokerage sees stronger growth in non-tobacco businesses.
- Kotak thinks splitting ITC’s tobacco and non-tobacco operations could unlock significant shareholder value.
- Risk flag: Regulatory risks for the tobacco business